PARP1 and tuberculosis: To gain insight into the functional consequences of PARP1 inhibition during TB therapy, we next evaluated disease progression, lung inflammation, and immune responses in chronically M.tb-infected C3HeB/FeJ mice treated with PZA or Tp alone or in combination with RIF for two months (Fig. 4; Supplementary Figs. 5–8).